Our preliminary anatomical studies suggest that EGR1 and NR4A2, as well as ADM (a downstream target of NR4A2 that was also significantly downregulated in MDD), are widely expressed, but are enriched in their expression within the DR. This evidence concerns the gene NR4A2 and major depressive disorder.